Colorectal Cancer Clinical Trial
Official title:
Health Behaviors Among Individuals Diagnosed With Colorectal Cancer
RATIONALE: Gathering information over time from patients who have finished treatment for
colorectal cancer may help doctors predict which cancer survivors will improve their physical
activity and diet.
PURPOSE: This clinical trial is studying health behaviors in patients who have finished
treatment for stage I, stage II, or stage III colorectal cancer.
OBJECTIVES:
Primary
- To characterize patterns and identify predictors of post-treatment physical activity and
dietary changes made by colorectal cancer survivors.
Secondary
- To identify the affective and cognitive effects of post-treatment physical activity and
dietary changes in these patients.
- To identify these patients' preferences regarding diet and physical activity health
promotion programs.
OUTLINE: This is a multicenter study.
Patients complete surveys at baseline and at 3 and 6 months. A randomly selected subset of 84
patients also receive an activity monitor to be use at each of the 3 time points. The
acceptability of their use is assessed and whether activity levels change across the 3 time
points and the extent to which they are convergent with self-reported physical activity are
examined.
During each survey, questionnaires are administered to assess the following areas:
physical/medical characteristics (self-reported), self-efficacy for physical activity, fruit
and vegetable consumption, and dietary fat intake; outcome expectations for physical
activity, fruit and vegetable consumption, and dietary fat intake; physical activity and diet
behavioral self-regulation; illness representations (causal attributions and controllability
of recurrence); perceived risk of colorectal cancer (CRC) recurrence; emotional
representations of CRC (cancer-related anxiety and worry about cancer recurrence); healthcare
provider recommendations to alter physical activity and dietary intake; social influence from
important others; current physical activity and dietary intake; and diet and physical
activity program preferences. Patients who received the activity monitor are asked feedback
on acceptability of them.
Measures of sociodemographics and disease/treatment characteristics (via medical chart
review) are recorded.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |